| 51 |
27200496 | Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling. | 2017 Mar |
1 |
| 52 |
27435393 | Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder. | 2017 Jan 15 |
1 |
| 53 |
27484766 | Efficacy of Aidi Injection () on overexpression of P-glycoprotein induced by vinorelbine and cisplatin regimen in patients with non-small cell lung cancer. | 2017 Jul |
3 |
| 54 |
28012924 | MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp. | 2017 Feb |
3 |
| 55 |
28053596 | Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. | 2017 |
1 |
| 56 |
28340578 | ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling. | 2017 Mar 24 |
5 |
| 57 |
28382490 | Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells. | 2017 Sep |
1 |
| 58 |
28422725 | MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1. | 2017 May 16 |
6 |
| 59 |
28443990 | MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma. | 2017 Apr 20 |
1 |
| 60 |
28721581 | Autophagy regulated by lncRNA HOTAIR contributes to the cisplatin-induced resistance in endometrial cancer cells. | 2017 Oct |
5 |
| 61 |
29156767 | Enhancing conventional chemotherapy drug cisplatin-induced anti-tumor effects on human gastric cancer cells both in vitro and in vivo by Thymoquinone targeting PTEN gene. | 2017 Oct 17 |
1 |
| 62 |
29250186 | Knockdown of long non-coding RNA HOTAIR sensitizes hepatocellular carcinoma cell to cisplatin by suppressing the STAT3/ABCB1 signaling pathway. | 2017 Dec |
1 |
| 63 |
29299132 | Saikosaponins A, C and D enhance liver-targeting effects of anticancer drugs by modulating drug transporters. | 2017 Dec 15 |
3 |
| 64 |
29979530 | [GGI as a gene carrier delivering MDR1 siRNA to A549/DDP cells for reversal of multidrug resistance]. | 2017 Feb |
1 |
| 65 |
26647959 | NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression. | 2016 Jan |
1 |
| 66 |
26717965 | HIF-1α/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer. | 2016 Mar |
1 |
| 67 |
26935266 | Insulin resistance contributes to multidrug resistance in HepG2 cells via activation of the PERK signaling pathway and upregulation of Bcl-2 and P-gp. | 2016 May |
2 |
| 68 |
27013200 | Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway. | 2016 May 15 |
3 |
| 69 |
27014910 | miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. | 2016 Apr 26 |
1 |
| 70 |
27284014 | Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation. | 2016 Jun 7 |
1 |
| 71 |
27295567 | MDR1 mediated chemoresistance: BMI1 and TIP60 in action. | 2016 Aug |
3 |
| 72 |
27460719 | Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein. | 2016 Jul |
1 |
| 73 |
27499034 | Downregulation of DNA-PKcs suppresses P-gp expression via inhibition of the Akt/NF-κB pathway in CD133-positive osteosarcoma MG-63 cells. | 2016 Oct |
1 |
| 74 |
27572875 | Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells. | 2016 Sep |
1 |
| 75 |
27629782 | Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance. | 2016 Dec |
1 |
| 76 |
27893429 | MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1. | 2016 Dec 27 |
2 |
| 77 |
27995666 | Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line. | 2016 Dec |
7 |
| 78 |
25253429 | MDR1 and cytochrome P450 gene-expression profiles as markers of chemosensitivity in human chronic myelogenous leukemia cells treated with cisplatin and Ru(III) metallocomplexes. | 2015 Feb |
3 |
| 79 |
25308861 | Myeloid differentiation factor 88 promotes cisplatin chemoresistance in ovarian cancer. | 2015 Mar |
4 |
| 80 |
25560468 | Predicting chemosensitivity to gemcitabine and cisplatin based on gene polymorphisms and mRNA expression in non-small-cell lung cancer cells. | 2015 Jan |
1 |
| 81 |
25579168 | Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression. | 2015 Feb |
2 |
| 82 |
25959925 | Multifunctional selenium nanoparticles: Chiral selectivity of delivering MDR-siRNA for reversal of multidrug resistance and real-time biofluorescence imaging. | 2015 Oct |
2 |
| 83 |
25960213 | Homology modelling and molecular docking of MDR1 with chemotherapeutic agents in non-small cell lung cancer. | 2015 Apr |
1 |
| 84 |
26004871 | Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells. | 2015 Aug 1 |
1 |
| 85 |
26043084 | MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells. | 2015 |
1 |
| 86 |
26063766 | Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin. | 2015 Aug |
3 |
| 87 |
26407653 | Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2. | 2015 Dec 15 |
2 |
| 88 |
26626440 | MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1. | 2015 Dec 2 |
2 |
| 89 |
23956061 | PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line. | 2014 Apr |
1 |
| 90 |
25099308 | Decreased P-glycoprotein is associated with the inhibitory effects of static magnetic fields and cisplatin on K562 cells. | 2014 Sep |
2 |
| 91 |
25276252 | Effect of TRAIL in combination with DDP on the expression of MDR1 gene in gastric cancer cells. | 2014 |
2 |
| 92 |
23135908 | Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. | 2013 Jan 1 |
1 |
| 93 |
23466650 | Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells. | 2013 Jun |
1 |
| 94 |
23672493 | Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells. | 2013 May 14 |
1 |
| 95 |
23917396 | Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells. | 2013 Oct |
1 |
| 96 |
24062304 | P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration. | 2013 Nov 1 |
1 |
| 97 |
22245869 | Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells. | 2012 Apr |
1 |
| 98 |
22364296 | Silence of p15 expression by RNAi enhances cisplatin resistance in hepatocellular carcinoma cells. | 2012 Feb |
4 |
| 99 |
22432540 | Decreased expression of MDR1 in PEG-conjugated hemoglobin solution combined cisplatin treatment in a tumor xenograft model. | 2012 Aug |
2 |
| 100 |
22543673 | Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy. | 2012 Sep |
1 |